First DNA from National Psoriasis Victor Henschel BioBank released for study
The first-ever release of National Psoriasis Victor Henschel BioBank DNA samples brings millions of Americans struggling with psoriasis and psoriatic arthritis one step closer to a cure. Scientists will use the samples for research that hopes to uncover the unknowns about the genetics of psoriatic disease and its causes.
James T. Elder, M.D., Ph.D., professor of molecular genetic dermatology in the Department of Dermatology at the University of Michigan Health System, and his research team received the first 1,250 BioBank DNA samples on Sept. 1, 2010. They will use them to identify new genes that increase a person's risk for developing psoriasis and also examine the connection between psoriasis and other autoimmune diseases, such as Crohn's disease.
The National Psoriasis BioBank, started by the National Psoriasis Foundation in 2006, is a collection of DNA samples and clinical information used by scientists to advance the field of psoriasis genetics. Once it meets its completion goals, the BioBank will be the largest single collection of psoriasis DNA samples in the world.
"The BioBank is a critical resource for bringing us one step closer to a cure for psoriasis, and we are honored to partner with Dr. Elder and his team on this landmark project," said Rick Seiden, chair of the National Psoriasis Foundation Board of Trustees. "This endeavor would not be possible without the hundreds of people with and without psoriatic disease who donated DNA over the past four years. We thank all of them for their vital contribution to psoriasis research."
The BioBank honors Victor Henschel, a highly respected member of the psoriasis community who lived with psoriasis and psoriatic arthritis for 35 years. The Henschel family, many of whom also live with psoriatic disease, donated money to the Foundation to start the BioBank.
About the National Psoriasis Foundation
Celebrating 50 years of patient support, advocacy, research funding, and education, the National Psoriasis Foundation (NPF) is the world’s leading nonprofit fighting for individuals with psoriasis and psoriatic arthritis. NPF is on a continued mission to drive efforts to cure psoriatic disease and dramatically improve the lives of more than 8 million Americans affected by this chronic immune mediated disease. As part of that effort, in 2016 the NPF created a Patient Navigation Center to offer personalized assistance to everyone with psoriasis or psoriatic arthritis. In addition, the NPF has funded more than $17 million in research grants and fellowships to date. Learn more at www.psoriasis.org.